Mentax — CareFirst (Caremark)
Topical treatment of fungal infections as specified in each FDA-approved indication (e.g., tinea pedis, tinea cruris, tinea corporis, tinea versicolor, seborrheic dermatitis, diaper dermatitis with candidiasis)
Preferred products
- generic topical antifungal agents
Initial criteria
- The requested drug is NOT being used in a footbath.
- ONE of the following:
- • The patient experienced an inadequate treatment response to a generic topical antifungal agent.
- • The patient experienced an intolerance to a generic topical antifungal agent.
- • The patient has a contraindication that would prohibit a trial of a generic topical antifungal agent.
Approval duration
3 months